Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-03

FDA Approved: CLINDESSE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for CLINDESSE (clindamycin phosphate) filed by Padagis Israel Pharmaceuticals Ltd. The action pertains to a suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDESSE (CLINDAMYCIN PHOSPHATE)

Snippet

SUPPL AP for CLINDESSE (CLINDAMYCIN PHOSPHATE)